Biotech Evening@SGInnovate with BCS

SGInnovate and Biotech Connection Singapore would like to invite you to join our next upcoming seminar event. Three exciting topics will be covered:
Dr. Shawn Watson, Founder and CEO, Senescence Life Sciences
Age-related cognitive decline is the natural deterioration of our mental capabilities as we age. Research suggests the human brain begins to age as early as twenty, and undergoes accelerated degradation after the age of sixty-five. With 760 million people over the age of sixty-five, 44 million of which suffer from dementia, brain health has become the top concern for health-conscious individuals and governments across the globe.
Join us to find out the basic precepts of brain aging and how his company is using cutting edge research to redefine the landscape of brain health.[/bs-text]
Grace Park and Cole Sirucek, DocDoc
Consumer empowerment is long overdue in healthcare. Imagine being able to select a doctor for yourself or your loved ones based on data and not hearsay. DocDoc is using the latest in clinical informatics, big data, and customer service to empower the consumer to find the right doctor for their unique situation.
Join us to find out their journey to transform healthcare by empowering patients in their doctor discovery process.[/bs-text]
Yanling Toh, Co-Founder and COO, Nephtech
Just as the heartbeat is essential to survival of any living organism, so is the thrill to any kidney disease patient undergoing hemodialysis. This thrill refers to the vibrations of blood flow that indicate vascular health to these patients. With the global increasing ageing population, digital technology is key to improve current solutions for preventive health and chronic disease management. As more innovators begin on their journey, to ensure the survival of their ideas, there are various aspects in commercialization that can determine their success. These includes considerations on regulations, patentability and market assessments. I will share about NephTech’s commercialization journey and the thrill of being in a MedTech start-up.[/bs-text]